Risk Management in Medical Laboratories

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 32

Risk management in medical

laboratories
Ana Stavljenic-Rukavina
Zagreb, Croatia

Kornati Islands,
Croatia

The annual rate of illness and


injury reported for hospital
workers is 10% - about the

The most frequent occupationrelated illnesses among hc personel


respiratory

problems

infections

dermatitis
drug

or medication reactions

Reasons for the lack of emphasis


on employers health:

common notion that health


professionals are capable of
maintaining their health without
assistance
availability of informal consultation
with hospital physician
hospitals are oriented toward treating
disease rather than maintaining health

Accidents do not happen, they


are caused

Safety should be taught and implemented


on every level in the health care sector
Within health care environment, both
workers and patients are daily
confronted with various health and
safety hazards
Therefore, implementation of general
safety and risk reduction system is
mandatory

LABORATORY HAZARDS

Non-infectious

dusts
physical agents
chemical agents
mutagenic and
teratogenic
agents
skin irritants
stress (!)

Infectious

hepatitis
AIDS

Material Safety Data


Sheets (MSDS)

It is obligatory that the vendors supply


MSDS for the chemicals
Vendor should make sure that the facility
receives the MSDS before or along the
shipment of chemical product
MSDS must be available for each chemical
used in an operation
Emergency and first aid procedures and
handling precautions should be given in
writen form to professionals

Infectious occupational health


hazards

Hepatitis B: a model for transmission


of blood-borne patogens (10-40% of
health care workers have serologic
evidence of past or present infection)
Infection risk after needle puncture:

HBV: 5-40%
HCV: 1-10%
HIV: <0.5%

An individual is at risk for


HBV or HIV infection in
proportion to the extent at
which he/she is exposed to
blood and body fluids

Therefore, effective
protection against bloodborne diseases requires
universal observation of
common barrier precautions

....which simply means: within


healthcare environment, all
body fluids and tissues
should be treated as
infectious.
Equally important: waste
disposal!

COMPONENTS OF
MEDICAL SAFETY

Employee safety
Patient safety
Environment safety

ELEMENTS OF EMPLOYEE
SAFETY

Blood and body fluid exposures


Allergies
Communicable disease exposures
Musculoskeletal injuries
Immunization program
Systematic review, follow-up, and
reporting of employee incidents

Levels of Biosafety

BSL 1: Material not known to consistently cause


disease in healthy adults.
BSL 2: Associated with human disease. Hazard
is from percutaneous injury, ingestion, or
mucous membrane exposure.
BSL 3: Indigenous or exotic agents with
potential for aerosol transmission; disease may
have serious or lethal consequences.
BSL 4: Dangerous/exotic agents which pose a
high risk of life-threatening disease, aerosoltransmitted lab infections or related agents
with unknown risk of transmission.

Risk Assessment

Pathogenicity of material disease incidence and


severity
Routes of Transmission parenteral, airborne or
ingestion
Agent Stability ease of decontamination
Infectious Dose LD50
Concentration infectious organisms/vol. & working
volume
Origin of material - Wild Type, primary cells
Availability of effective prophylaxis Hep. B
vaccine
Medical surveillance exposure management
Skill level of staff

Risk Assessment

Risk of Activity same agent can have


different containment levels at different
stages of protocol:
Procedures that produce aerosols have
higher risk
Procedures using needles or other sharps
have higher risk
Handling blood, serum or tissue samples
may have lower risk
Purified cultures or cell concentrates may
have higher risk
Larger volumes (10 L) have higher risk

Primary Containment

Lab practices SOP regulating access,


biohazard warning sign, sharps/needle
precautions, SOPs for decontamination and
waste.
Safety equipment biosafety cabinets
(BSC), sharps containers, sealed rotors.
Personal protective equipment (PPE) : coat,
gloves, goggles.
Host-vector for rDNA

Aerosol Precautions

Use BSC for all procedures that may


generate aerosols.
Use centrifuges with biosafety covers.
Do not use a syringe for mixing infectious
fluids.
Cultures, tissues, specimens of body fluids,
etc., are placed in a container with a cover
that prevents leakage during collection,
handling, processing, storage, transport or
shipping.

Needle and Sharps


Precautions

Precautions are for any


contaminated sharp item,
including needles and syringes,
slides, pipettes, capillary tubes,
and scalpels.
Plasticware should be substituted
for glassware whenever possible.

Needle and Sharps


Precautions

Used disposable needles must not be bent,


sheared, broken, recapped, removed from
disposable syringes, or otherwise manipulated
by hand before disposal. Dispose in punctureresistant containers which must be located
near work.
Non-disposable sharps must be placed in a
hard-walled container for transport to a
processing area for decontamination,
preferably by autoclaving.
Broken glassware must not be handled directly
by hand.Pick up by mechanical means such as a
brush and dustpan, tongs, or forceps.

Human Blood, Tissue and Fluid


Occupational Exposure to Bloodborne Pathogens

Use BSL 2 work practices and procedures.


Additional requirements for HIV work.
Everyone needs to be offered the Hepatitis B
vaccine.
Develop specific exposure plan SOPs.
Specific training is required.
Review needle/syringe use and replace with
safe devices.
Exposure incidents must be followed up.

Toxins

Use BSL 2 work practices and


procedures.
Develop a Chemical Hygiene Plan
specific to the toxin used.
Include containment (hoods,
biosafety cabinets).
Some toxins are Select Agents
and require registration.

Select Agents

Possession, use and transfer of


specific biological agents requires
registration.
Restricted Persons are not allowed
to have access to these agents.
High security and containment must
be maintained.

Security

Control access to areas where biological


agents or toxins are used and stored.
Keep biological agents and toxins in
locked containers.
Know who is in the laboratory, what
materials are being brought and what
materials are being removed from the
laboratory.
Have a protocol for reporting incidents.
Have an emergency plan.

Emergencies
Develop and practice plans for:

Spills: large spills, spills inside BSC


Accidental exposures: needlesticks,
eye/mucous membrane splash, breathing
aerosols
Power/Utility failures: BSC, freezers,
ventilation, lights, water
Fires
Medical emergencies

Waste Disposal
Red bag or Regulated Medical Waste:

All mammalian cells or anything that came


in contact with mammalian cells
All BSL 2 material or anything that came
in contact with BSL 2 material
All needles/syringes regardless of use
No need to autoclave this waste prior to
disposal in EH&S red bag/box (material is
incinerated).

CRITICAL ELEMENTS
CREATING A SAFETY CULTURE

Demonstrate top leadership commitment to


safety
Swift and visible correction of unsafe
conditions
Established procedures for reporting
unsafe conditions
Reward workers for following procedures
Involve frontline healthcare workers in
identifying problems and solutions

Role of management
The scope: identifying problem
areas and exerting specific
actions to correct them

Development of Safety
Program

Recognition of hazards
Determination (evaluation) of
hazards
Baseline health and safety survey
Sampling strategy
Health and safety plan

Risk management
RISK ASSESSMENT (GENERIC)
|
TAKE THE DESIGN INTENTION
l
CHANGE IT BY "GUIDE WORDS"
l
CREATE HYPOTHETICAL DEVIATIONS
l
CREATE IMAGES
l
STIMULATE IMAGINATIONS OF THE TEAM TO SEARCH DATA FOR REAL
DEVIATIONS
l
EXAMINE CAUSES AND CONSEQUENCE
HARMLESS
IGNORE

HARMFUL
ELIMINATE OR CONTROL

Regulations

OSHA Bloodborne Pathogens


http://www.osha.gov/SLTC/bloodbornepathogens/index.html
CDC Select Agents
http://www.cdc.gov/od/ohs/lrsat.htm
NIH Guidelines for Research Involving Recombinant DNA
Molecules
http://www4.od.nih.gov/oba/rac/guidelines/guidelines.html
DOT/CDC Shipping
http://www.cdc.gov/od/ohs/biosfty/shipregs.htm
CDC Import Permits

http://www.cdc.gov/od/ohs/biosfty/imprtper.htm
USDA/APHIS Permits

http://www.aphis.usda.gov/vs/ncie/

Resources

CDC Biosafety in Microbiological and


Biomedical Laboratories

http://www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4toc.ht
m

ABSA Risk Groups

http://www.absa.org/riskgroups/index.htm

Canadian MSDSs

http://www.hc-sc.gc.ca/pphb-dgspsp/msds-ftss/index.h
tml

Environmental Health & Safety Lab


Safety

You might also like